Clarke, PhD
Senior Director and Head of Respiratory & Inflammation, Early Clinical Development
Graham Clarke, PhD, is the senior director and head of the respiratory and inflammation unit in Early Clinical Development. He leads the development and execution of inhaler generics and inhaler characterization studies in broncho-protection and broncho-dilation bioequivalence programs. He also leads Quintiles’ biomarker identification efforts and the development of challenge models of inflammation. 

Dr. Clarke joined Quintiles in 2008 as the therapeutic area head for respiratory responsible for developing patient strategy and biomarker development initiatives. In that role, he contributed to new integrated approaches for drug development across Quintiles — including patient recruitment strategy, protocol design and optimizing biomarker read-outs. 

After training as a clinical physiologist at the Royal Brompton Hospital, London, Dr. Clarke served in a variety of respiratory clinical research environments. He is the former editor of Inspire, the journal of the Association for Respiratory Technology and Physiology, and he is a senior research fellow in cardiothoracic pharmacology at Imperial College London’s National Heart and Lung Institute, where he contributes to the research and medical degree teaching programs. Dr. Clarke completed a PhD in respiratory pharmacology and physiology with focus on airway and vascular hyper-responsiveness in asthma at King’s College, London.


Connect with Graham Clarke, PhD

Media Inquiries

Request and interview with Graham